4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-181.14M
↓ 147% below average
Average (7y)
$-73.43M
Historical baseline
Range
High:$-9.70M
Low:$-181.14M
CAGR
+49.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-181.14M | -66.7% |
| 2023 | $-108.66M | -1.0% |
| 2022 | $-107.63M | -54.2% |
| 2021 | $-69.81M | -26.4% |
| 2020 | $-55.22M | -23.8% |
| 2019 | $-44.62M | -359.9% |
| 2018 | $-9.70M | +8.9% |
| 2017 | $-10.65M | - |